@article{article, title  = {{Determinants of response of HER2+ gastric cancer (GC) vs gastroesophageal junction adenocarcinoma (GEJ) to margetuximab (M) plus pembrolizumab (P) post trastuzumab (T)}},

 publisher = {{Elsevier BV}},

 url = {{https://doi.org/10.1093/annonc/mdz253.015 }},

 year = {{2019}},

 month = {{10}},

 author = {{Park H and Uronis H and Kang Y-K and Ng MCH and Enzinger P and Lee KW and Rutella S and Church SE and Nordstrom J and Knutson K and Erskine C et al}},

 doi = {{10.1093/annonc/mdz253.015}},

 volume = {{30}},

 journal = {{Annals of Oncology}},

 pages = {{v485-v485}},

 note = {{Accessed on 2026/02/25}}}